Literature DB >> 7681257

Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

L Leoncini1, M T Del Vecchio, T Megha, P Barbini, P Galieni, S Pileri, E Sabattini, F Gherlinzoni, P Tosi, R Kraft.   

Abstract

Cell production versus cell loss rates were estimated, across the boundaries of histological classification, in 50 cases of malignant non-Hodgkin's lymphomas by use of mitotic indices, percentage of Ki-67+ cells and percentage of PC10+ cells as proliferative indices, and the relative number of apoptotic bodies (apoptotic indices, AIs) as parameters. Regression analysis revealed significant (P < 0.01) positive correlations between the AIs and the proliferative indices; among the immunohistochemically assessed proliferative indices; and between these, the mitotic indices and the AIs on the one hand and histological malignancy grades on the other hand. The cellular protein BCL-2, which counteracts apoptosis, was significantly (P < 0.01) more often expressed in lymphomas with low than in those with high AIs. Multivariate analysis of data showed that of all parameters tested in this series, only the AIs correlated significantly (P < 0.05) with overall lethality. The correlation between BCL-2 positivity of lymphoma cells and overall survival did not quite attain significance (P = 0.08). Results of the present study suggest that high AIs and lack of BCL-2 expression may be adverse prognostic factors, independent of histological grade.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681257      PMCID: PMC1886795     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections.

Authors:  S Pileri; B Falini; E Sabattini; B Bigerna; F Gherlinzoni; P L Tazzari
Journal:  Haematologica       Date:  1991 May-Jun       Impact factor: 9.941

Review 2.  Mechanisms of cell death.

Authors:  D J Fawthrop; A R Boobis; D S Davies
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Apoptosis: cell death under homeostatic control.

Authors:  A H Wyllie
Journal:  Arch Toxicol Suppl       Date:  1987

4.  Updated Kiel classification for lymphomas.

Authors:  A G Stansfeld; J Diebold; H Noel; Y Kapanci; F Rilke; G Kelényi; C Sundstrom; K Lennert; J A van Unnik; O Mioduszewska
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  The biology of cell death in tumours.

Authors:  A H Wyllie
Journal:  Anticancer Res       Date:  1985 Jan-Feb       Impact factor: 2.480

7.  Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.

Authors:  L M Weiss; J G Strickler; L J Medeiros; J Gerdes; H Stein; R A Warnke
Journal:  Hum Pathol       Date:  1987-11       Impact factor: 3.466

8.  Image analysis applied to proliferating cells in malignant lymphoma.

Authors:  C Souchier; M Ffrench; F Berger; J Y Scoazec; P A Bryon
Journal:  Cytometry       Date:  1988-05

9.  Mitosis counts: reproducibility and significance in grading of malignancy.

Authors:  K Donhuijsen
Journal:  Hum Pathol       Date:  1986-11       Impact factor: 3.466

10.  Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.

Authors:  M Akerman; L Brandt; A Johnson; H Olsson
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

View more
  48 in total

Review 1.  Spreading the word: non-autonomous effects of apoptosis during development, regeneration and disease.

Authors:  Ainhoa Pérez-Garijo; Hermann Steller
Journal:  Development       Date:  2015-10-01       Impact factor: 6.868

2.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

4.  Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy.

Authors:  J R Paxton; B S Bolger; A Armour; R P Symonds; J H Mao; R A Burnett
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

5.  Abl expression, tumour grade, and apoptosis in chondrosarcoma.

Authors:  M O'Donovan; J M Russell; J J O'Leary; J A Gillan; M P Lawler; E F Gaffney
Journal:  Mol Pathol       Date:  1999-12

6.  Relationship of Helicobacter pylori to Bcl-2 family expression, DNA content, and pathological characteristics of gastric cancer.

Authors:  Mohamed El-Shahat; Samir El-Masry; Mahmoud Lotfy; Ayman El-Meghawry El-Kenawy; Wesam A Nasif
Journal:  Int J Gastrointest Cancer       Date:  2005

7.  Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells.

Authors:  T Kaneko; H Saito; T Takahashi; N Ohta; T Saito; M Hiroi
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

8.  bcl-2 protein expression in tumors of the central nervous system.

Authors:  S Nakasu; Y Nakasu; H Nioka; M Nakajima; J Handa
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.

Authors:  T Efferth; U Fabry; P Glatte; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Bcl-2 protein expression and long-term survival in breast cancer.

Authors:  H Joensuu; L Pylkkänen; S Toikkanen
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.